Naturally." - Brand-stated positioning
Dehestani B, Stratford NR, le Roux CW
While compounded medications may seem appealing because of their lower prices and easier access during drug shortages, they can come with real safety risks
In a 2018 guidance, FDA explained that it would consider a compounded drug to be essentially a copy of a commercially available drug if it has (i) the same API, (ii) the same or similar dosage, and (iii) the same route of administration, unless a prescriber determines that there is a change, made for an identified individual patient, which produces, for that patient, a significant difference from the commercially available drug product. The guidance also explains that, if a change is made for an identified patient, the prescriber should document the determination on the prescription, and the notations should be specific
While trends change quickly, the fundamentals remain: fair odds, fast payouts, and excellent support